tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

INDP Stock Latest News

Indaptus Therapeutics Reports Mixed Results in Clinical Trial
Company AnnouncementsIndaptus Therapeutics Reports Mixed Results in Clinical Trial
28d ago
8K
INDP
Indaptus Therapeutics provides update on INDP-D101 clinical trial
PremiumThe Fly
Indaptus Therapeutics provides update on INDP-D101 clinical trial
28d ago
INDP
Indaptus Therapeutics files to sell 781,250 shares of common stock, warrants
PremiumThe Fly
Indaptus Therapeutics files to sell 781,250 shares of common stock, warrants
1M ago
INDP
Indaptus Therapeutics files $200M mixed securities shelf
PremiumThe Fly
Indaptus Therapeutics files $200M mixed securities shelf
2M ago
INDP
Indaptus Therapeutics files to sell 2.16M shares of common stock for holders
PremiumThe Fly
Indaptus Therapeutics files to sell 2.16M shares of common stock for holders
2M ago
INDP
Indaptus Therapeutics reports Q2 EPS ($9.09) vs ($13.16) last year
PremiumThe FlyIndaptus Therapeutics reports Q2 EPS ($9.09) vs ($13.16) last year
2M ago
INDP
Indaptus Therapeutics Secures Approval for Private Placement
Premium
Company Announcements
Indaptus Therapeutics Secures Approval for Private Placement
2M ago
8K
INDP
Indaptus Regains Nasdaq Compliance with Bid Price
Premium
Company Announcements
Indaptus Regains Nasdaq Compliance with Bid Price
3M ago
8K
INDP
Indaptus Therapeutics Raises $5.7M for R&D Initiatives
PremiumCompany Announcements
Indaptus Therapeutics Raises $5.7M for R&D Initiatives
3M ago
8K
INDP
Indaptus Therapeutics announces additional sale of $3.4M in private placement
PremiumThe Fly
Indaptus Therapeutics announces additional sale of $3.4M in private placement
3M ago
INDP
Indaptus Therapeutics Inc trading resumes
PremiumThe Fly
Indaptus Therapeutics Inc trading resumes
3M ago
INDP
Indaptus Therapeutics Inc trading halted, volatility trading pause
PremiumThe Fly
Indaptus Therapeutics Inc trading halted, volatility trading pause
3M ago
INDP
Indaptus Therapeutics Inc trading halted, news pending
PremiumThe FlyIndaptus Therapeutics Inc trading halted, news pending
3M ago
INDP
Indaptus Therapeutics Announces Reverse Stock Split
Premium
Company Announcements
Indaptus Therapeutics Announces Reverse Stock Split
3M ago
8K
INDP
Indaptus Therapeutics board approves 1-for-28 reverse stock split
Premium
The Fly
Indaptus Therapeutics board approves 1-for-28 reverse stock split
3M ago
INDP
3 Penny Stocks to Watch Now, 6/24/25
PremiumMarket News
3 Penny Stocks to Watch Now, 6/24/25
3M ago
OP
INDO
Indaptus Therapeutics Completes $2.3M Private Placement
PremiumCompany Announcements
Indaptus Therapeutics Completes $2.3M Private Placement
4M ago
8K
INDP
Indaptus Therapeutics announces sale of $2.3M of convertible notes, warrants
PremiumThe Fly
Indaptus Therapeutics announces sale of $2.3M of convertible notes, warrants
4M ago
INDP
Indaptus Therapeutics Approves Key Proposals at Annual Meeting
PremiumCompany Announcements
Indaptus Therapeutics Approves Key Proposals at Annual Meeting
4M ago
8K
INDP
Indaptus Therapeutics: Promising Clinical Developments and Strategic Advances Justify Buy Rating
PremiumRatingsIndaptus Therapeutics: Promising Clinical Developments and Strategic Advances Justify Buy Rating
4M ago
INDP
Indaptus doses first patient in Phase 1b.2 study of Decoy20 withTislelizumab
Premium
The Fly
Indaptus doses first patient in Phase 1b.2 study of Decoy20 withTislelizumab
4M ago
ONC
INDP
Positive Outlook for Indaptus Therapeutics Amid Promising Clinical Trial Advancements and Innovative Decoy20 Platform
Premium
Ratings
Positive Outlook for Indaptus Therapeutics Amid Promising Clinical Trial Advancements and Innovative Decoy20 Platform
5M ago
INDP

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >